-+ 0.00%
-+ 0.00%
-+ 0.00%
Wei Xinkang announced that according to notifications from the National Health Insurance Administration and the Ministry of Human Resources and Social Security, the company's wholly-owned subsidiary, Inner Mongolia Baiyi Pharmaceutical Co., Ltd. Pediatric multivitamin injections were renewed and included in the “National Medical Insurance Catalogue” during the agreement period. The drug is classified as Class B 73. The agreement is valid from January 1, 2027 to December 31, 2028
Share
Listen to the news
Wei Xinkang announced that according to notifications from the National Health Insurance Administration and the Ministry of Human Resources and Social Security, the company's wholly-owned subsidiary, Inner Mongolia Baiyi Pharmaceutical Co., Ltd. Pediatric multivitamin injections were renewed and included in the “National Medical Insurance Catalogue” during the agreement period. The drug is classified as Class B 73. The agreement is valid from January 1, 2027 to December 31, 2028
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending